title: Ethanol enhances glutamate transmission by retrograde dopamine signaling in a postsynaptic neuron/synaptic bouton preparation from the ventral tegmental area.
abstract: It is well documented that somatodendritically released dopamine is important in the excitability and synaptic transmission of midbrain dopaminergic neurons. Recently we showed that in midbrain slices, acute ethanol exposure facilitates glutamatergic transmission onto dopaminergic neurons in the ventral tegmental area (VTA). The VTA is a brain region critical to the rewarding effects of abused drugs, including ethanol. We hypothesized that ethanol facilitation might result from an increase in somatodendritically released dopamine, which acts retrogradely on dopamine D(1) receptors on glutamate-releasing axons and consequently leads to an increase in glutamate release onto dopaminergic neurons. To further test this hypothesis and to examine whether ethanol facilitation can occur at the single-cell level, VTA neurons were freshly isolated from rat brains using an enzyme-free procedure. These isolated neurons retain functional synaptic terminals, including those that release glutamate. Spontaneous excitatory postsynaptic currents (sEPSCs) mediated by glutamate alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors were recorded from these freshly isolated putative dopaminergic neurons. We found that acute application of clinically relevant concentrations of ethanol (10-80 mM) significantly facilitated the frequency of sEPSCs but not their mean amplitude. Ethanol facilitation was mimicked by the D(1) agonist SKF 38393 and by the dopamine uptake blocker GBR 12935 but was blocked by the D(1) antagonist SKF 83566, and by depleting dopamine stores with reserpine, as well as by chelating postsynaptic calcium with BAPTA. Furthermore, the sodium channel blocker tetrodotoxin eliminated the facilitation of sEPSCs induced by ethanol but not by SKF 38393. These results constitute the first evidence from single isolated cells of ethanol facilitation of glutamate transmission to dopaminergic neurons in the VTA. In addition, we show that ethanol facilitation has a postsynaptic origin and a presynaptic locus. Furthermore, ethanol stimulation of a single dopaminergic neuron is capable of eliciting the release of somatodendritic dopamine, which is sufficient to influence glutamatergic transmission at individual synapses.
authors.affiliation: Department of Anesthesiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, NJ 07103-2714, USA.
authors.forename: Chunyu
authors.initials: C
authors.lastname: Deng
authors.forename: Ke-Yong
authors.initials: KY
authors.lastname: Li
authors.forename: Chunyi
authors.initials: C
authors.lastname: Zhou
authors.forename: Jiang-Hong
authors.initials: JH
authors.lastname: Ye
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D002492:Central Nervous System Depressants / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000378:metabolism; D000431:Ethanol / Q000494:pharmacology*; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D018698:Glutamic Acid / Q000378:metabolism*; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D051381:Rats; D017207:Rats, Sprague-Dawley; D017447:Receptors, Dopamine D1 / Q000819:agonists / Q000037:antagonists & inhibitors; D017470:Receptors, Glutamate / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D026941:Sodium Channel Blockers / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects*; D017557:Ventral Tegmental Area / Q000187:drug effects* / Q000502:physiology
chemical_list: D002492:Central Nervous System Depressants; D002614:Chelating Agents; D015259:Dopamine Agents; D017447:Receptors, Dopamine D1; D017470:Receptors, Glutamate; D026941:Sodium Channel Blockers; D000431:Ethanol; D018698:Glutamic Acid; D002118:Calcium; D004298:Dopamine
references.citation: J Neurophysiol. 2007 Mar;97(3):1977-85
references.pmid: 16956995
references.citation: Neuroscience. 2006;138(1):25-35
references.pmid: 16378694
references.citation: J Neurosci. 1999 Nov 15;19(22):9780-7
references.pmid: 10559387
references.citation: Brain Res Rev. 2008 Aug;58(2):290-302
references.pmid: 18042492
references.citation: J Neurosci. 1987 Sep;7(9):2794-806
references.pmid: 3625274
references.citation: J Neurosci. 2005 Jun 29;25(26):6199-207
references.pmid: 15987949
references.citation: Brain Res. 1985 Nov 25;348(1):201-3
references.pmid: 2998561
references.citation: Proc Natl Acad Sci U S A. 1982 Jul;79(14):4456-60
references.pmid: 6956874
references.citation: J Pharmacol Exp Ther. 1999 Jul;290(1):325-33
references.pmid: 10381795
references.citation: Alcohol. 1996 Nov-Dec;13(6):569-74
references.pmid: 8949951
references.citation: J Neurochem. 2005 Jun;93(6):1469-81
references.pmid: 15935063
references.citation: Alcohol Clin Exp Res. 2008 Apr;32(4):690-8
references.pmid: 18341645
references.citation: Neuropsychopharmacology. 2009 Jan;34(2):307-18
references.pmid: 18596684
references.citation: J Pharmacol Exp Ther. 2006 Jun;317(3):1155-60
references.pmid: 16501066
references.citation: J Physiol. 1987 Apr;385:243-86
references.pmid: 2443667
references.citation: Brain Res. 1990 Jan 29;508(1):65-9
references.pmid: 2337793
references.citation: Brain Res. 2005 Oct 26;1060(1-2):126-37
references.pmid: 16212943
references.citation: J Neurosci. 2006 Mar 8;26(10):2788-97
references.pmid: 16525058
references.citation: J Neurosci. 1997 Aug 1;17(15):5738-46
references.pmid: 9221772
references.citation: J Neurosci. 2004 Oct 13;24(41):8961-74
references.pmid: 15483115
references.citation: Nature. 1981 Feb 12;289(5798):537-42
references.pmid: 6258083
references.citation: Pharmacol Ther. 2005 Jul;107(1):80-98
references.pmid: 15963352
references.citation: Science. 1989 Mar 31;243(4899):1721-4
references.pmid: 2467382
references.citation: Neurochem Int. 2006 Dec;49(8):737-45
references.pmid: 16901588
references.citation: Brain Res. 1975 Jan 17;83(3):531-7
references.pmid: 1111820
references.citation: J Neurosci. 1989 Apr;9(4):1233-41
references.pmid: 2703874
references.citation: Exp Brain Res. 1994;100(3):395-406
references.pmid: 7813678
references.citation: J Psychiatry Neurosci. 2004 Jul;29(4):296-310
references.pmid: 15309046
references.citation: J Neurosci. 1995 Jul;15(7 Pt 2):5379-88
references.pmid: 7623160
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4904-9
references.pmid: 18347345
references.citation: Nature. 1976 Mar 18;260(5548):258-60
references.pmid: 1256567
references.citation: Neuroscience. 2008 Apr 22;153(1):240-8
references.pmid: 18343590
references.citation: Science. 2001 Sep 28;293(5539):2465-70
references.pmid: 11577238
references.citation: Brain Res. 1984 Feb 27;294(1):127-32
references.pmid: 6697228
references.citation: J Neurochem. 1990 Dec;55(6):2111-6
references.pmid: 1977890
references.citation: J Physiol. 2000 Feb 15;523 Pt 1:163-73
references.pmid: 10673553
references.citation: J Neurophysiol. 2006 Feb;95(2):619-26
references.pmid: 16148268
references.citation: J Comp Neurol. 1997 Nov 24;388(3):484-94
references.pmid: 9368855
references.citation: J Neurosci Methods. 2006 Dec 15;158(2):251-9
references.pmid: 16842860
references.citation: Neuron. 2004 Jun 24;42(6):939-46
references.pmid: 15207238
references.citation: Brain Res Brain Res Rev. 1997 Dec;25(3):312-34
references.pmid: 9495561
references.citation: J Neurosci. 2006 Sep 27;26(39):10043-50
references.pmid: 17005867
references.citation: Brain Res. 1990 Jul 30;524(1):31-41
references.pmid: 2400930
references.citation: Eur J Pharmacol. 1997 Apr 11;324(1):1-10
references.pmid: 9137907
references.citation: J Neurosci. 1997 Apr 1;17(7):2519-30
references.pmid: 9065512
references.citation: Trends Pharmacol Sci. 2003 Jan;24(1):44-7
references.pmid: 12498731
references.citation: J Neurochem. 2000 Oct;75(4):1685-93
references.pmid: 10987851
references.citation: J Physiol. 2006 Dec 15;577(Pt 3):907-24
references.pmid: 16959856
references.citation: J Neurosci. 2007 May 23;27(21):5730-43
references.pmid: 17522317
references.citation: Eur J Neurosci. 2007 Jan;25(1):106-18
references.pmid: 17241272
references.citation: Alcohol Clin Exp Res. 2007 Jul;31(7):1106-13
references.pmid: 17577392
references.citation: Biochem Pharmacol. 2008 Jan 1;75(1):218-65
references.pmid: 17706608
references.citation: J Neurochem. 1991 Mar;56(3):961-7
references.pmid: 1993900
references.citation: Adv Biochem Psychopharmacol. 1977;16:433-8
references.pmid: 883551
references.citation: J Neurosci. 1996 Jul 1;16(13):4135-45
references.pmid: 8753875
references.citation: Neurosci Lett. 2007 Oct 2;425(3):188-91
references.pmid: 17845833
references.citation: J Neurosci. 2004 Jan 7;24(1):53-62
references.pmid: 14715937
references.citation: Neurosci Biobehav Rev. 2004 Jul;28(4):415-31
references.pmid: 15289006
references.citation: Alcohol Clin Exp Res. 2008 Jun;32(6):1040-8
references.pmid: 18422836
references.citation: J Neurosci. 2004 Nov 24;24(47):10652-9
references.pmid: 15564581
references.citation: Alcohol Clin Exp Res. 2003 Oct;27(10):1573-82
references.pmid: 14574227
references.citation: Br J Pharmacol. 2002 Feb;135(3):816-22
references.pmid: 11834630
references.citation: J Neurosci. 2006 Aug 16;26(33):8549-58
references.pmid: 16914681
references.citation: Alcohol Clin Exp Res. 1999 Nov;23(11):1848-52
references.pmid: 10591603
references.citation: Alcohol Clin Exp Res. 1998 Aug;22(5):998-1040
references.pmid: 9726269
references.citation: Neurochem Res. 1995 Feb;20(2):159-69
references.pmid: 7783840
references.citation: J Neurosci. 2004 Feb 4;24(5):1050-7
references.pmid: 14762123
references.citation: Nature. 1993 Nov 25;366(6453):344-7
references.pmid: 8247128
references.citation: Neuroscience. 1996 Feb;70(4):1025-37
references.pmid: 8848165
references.citation: J Pharmacol Exp Ther. 2004 Oct;311(1):282-9
references.pmid: 15169831